AB-218

· AnHeart Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AB-218, covering 2024-10-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma [EARLY_Phase 1]